Abstract:BACKGROUND:Liver fibrosis is a wound-healing response to chronic injury, featuring with excess accumulation of extracellular matrix secreted by the activated hepatic stellate cells (HSC). Disulfiram (DSF), also known as Antabuse, has been used for the treatment of alcohol addiction and substance abuse. Recently, overwhelming studies had revealed anti-cancer effects of DSF in multiple cancers, including liver cancer. But the actual effects of DSF on liver fibrosis and liver function remain unknown.METHODS:In this study, we evaluated the effects of low-dose DSF in CCl4- and Bile Duct Ligation (BDL)-induced hepatic fibrosis rat models. Cell proliferation was detected by using the Cell-Light™ EdU Apollo®567 Cell Tracking Kit. Cell apoptosis was analyzed using a TdT-mediated dUTP nick end labeling (TUNEL) kit, viability was measured with Cell Counting Kit-8(CCK8). Relative mRNA expression of pro-fibrogenic was assessed using quantitative RT-PCR. The degree of liver fibrosis, activated HSCs, were separately evaluated through Sirius Red-staining, immunohistochemistry and immunofluorescence. Serum alanine aminotransferase (ALT) and asparagine aminotransferase (AST) activities were detected with ALT and AST detecting kits using an automated analyzer.RESULTS:Liver fibrosis was distinctly attenuated while liver functions were moderately ameliorated in the DSF-treated group. Activation and proliferation of primary rat HSCs isolated from rat livers were significantly suppressed by low-dose DSF. DSF also inhibited the viability of in vitro cultured rat or human HSC cells dose-dependently but had no repressive role on human immortalized hepatocyte THLE-2 cells. Interestingly, upon DSF treatment, the viability of LX-2 cells co-cultured with THLE-2 was significantly inhibited, while that of THLE-2 co-cultured with LX-2 was increased. Further study indicated that HSCs apoptosis was increased in DSF/CCl4-treated liver samples. These data indicated that DSF has potent anti-fibrosis effects and protective effects toward hepatocytes and could possibly be repurposed as an anti-fibrosis drug in the clinic.CONCLUSIONS:DSF attenuated ECM remodeling through suppressing the transformation of quiet HSCs into proliferative, fibrogenic myofibroblasts in hepatic fibrosis rat models. DSF provides a novel approach for the treatment of liver fibrosis.

Diallyl trisulfide attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic oxidative stress in rats

The Effect of Lecithins Coupled Decorin Nanoliposomes on Treatment of Carbon Tetrachloride-Induced Liver Fibrosis

Diallyl Trisulfide Protects The Liver Against Hepatotoxicity Induced By Isoniazid And Rifampin In Mice By Reducing Oxidative Stress And Activating Kupffer Cells

Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury.

Hepatoprotective Effect of Diallyl Trisulfide Against Lipopolysaccharide and D-galactosamine Induced Acute Liver Failure in Mice Via Suppressing Inflammation and Apoptosis.

The Therapeutic Effects of Tectorigenin on Chemically Induced Liver Fibrosis in Rats and an Associated Metabonomic Investigation

Danggui Shaoyao San: Chemical characterization and inhibition of oxidative stress and inflammation to treat CCl4-induced hepatic fibrosis

Tauroursodeoxycholic acid inhibits carbon tetrachloride-induced liver fibrosis in rats

Diallyl sulfide treatment protects against acetaminophen-/carbon tetrachloride-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice.

Disulfiram Inhibits Liver Fibrosis in Rats by Suppressing Hepatic Stellate Cell Activation and Viability

Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis

Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice.

Effects of 18Α-Glycyrrhizin on TGF-β1/Smad Signaling Pathway in Rats with Carbon Tetrachloride-Induced Liver Fibrosis.

Effects Of 18 Alpha-Glycyrrhizin On Tgf-Beta 1/Smad Signaling Pathway In Rats With Carbon Tetrachloride-Induced Liver Fibrosis

Diallyl Trisulfide Protects Against Concanavalin A-induced Acute Liver Injury in Mice by Inhibiting Inflammation, Oxidative Stress and Apoptosis.

Diisopropylamine Dichloroacetate Alleviates Liver Fibrosis Through Inhibiting Activation And Proliferation Of Hepatic Stellate Cells

Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro.

Protective Effect Of Diallyl Trisulfide Against Naphthalene-Induced Oxidative Stress And Inflammatory Damage In Mice

Ligustroflavone Ameliorates CCl4-induced Liver Fibrosis Through Down-Regulating the TGF-β/Smad Signaling Pathway.

Astilbin Protects Against Carbon Tetrachloride-Induced Liver Fibrosis in Rats

Diallyl trisulfide inhibits naphthalene-induced oxidative injury and the production of inflammatory responses in A549 cells and mice